{
    "clinical_study": {
        "@rank": "55246", 
        "acronym": "IMPROVE", 
        "arm_group": [
            {
                "arm_group_label": "Group A  Platelet Rich Plasma Injection (PRP)", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects randomized into this arm will receive an injection of Platelet Rich Plasma (PRP)."
            }, 
            {
                "arm_group_label": "Group B Whole Blood Injection", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects randomized into this arm will receive an injection of autologous whole blood."
            }, 
            {
                "arm_group_label": "Group C Dry needle tendon fenestration", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects enrolled into this arm will receive dry needling.  No blood will be injected into the tendon."
            }, 
            {
                "arm_group_label": "Group D  No injection", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects enrolled into this study will not receive any dry needling or any injection of blood into the tendon."
            }
        ], 
        "brief_summary": {
            "textblock": "This Pilot study is a Multicenter, Randomized Trial comparing autologous platelet rich\n      plasma (PRP) versus autologous whole blood versus dry needle tendon fenestration on pain and\n      quality of life in patients with lateral epicondylitis (tennis elbow).  We want to find out\n      if pain and mobility are improved in people whjo receive an injection of platelet rich\n      plasma(PRP)compared to a group of people wo receive an injection of whole blood, a group of\n      people who receive dry needle tendon fenestration and a group of people who receive no\n      injection."
        }, 
        "brief_title": "Impact of Platelet Rich Plasma Over Alternative Therapies in Patients With Lateral Epicondylitis", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Tennis Elbow", 
        "condition_browse": {
            "mesh_term": "Tennis Elbow"
        }, 
        "detailed_description": {
            "textblock": "Platlet rich plasma deserves study because it is more expensive than the other treatments.\n      If we find out that platelet rich plasma is better compared to the other treatments, it\n      would justify the high cost and growing industry associated with the procedure.  If we find\n      out that platelet rich plasma is not better compared to the other treatments, there is the\n      potential to save the health care system millions of dollars.\n\n      We hope to show that we can recruit eligible participants and complete the treatment and\n      tests we plan to use to answer the questions regarding the effectiveness of platelet rich\n      plasma for patients with tennis elbow."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age - 20 years or older\n\n          -  Have diagnosis of lateral epicondylitis (tennis elbow).\n\n          -  Symptoms lasting at least 3 months or longer.\n\n          -  Have pain on a scale of 1 to 10 at level 5\n\n             (1=no pain and 10=severe pain)\n\n          -  Documented sonographic diagnosis of common extensor tendinosis based on      tendon\n             thickening, areas of hypoechogenicity, and loss of the normal   echotexture.\n\n        Exclusion Criteria:\n\n          -  Acute symptom onset less than 3 months\n\n          -  History of acute elbow trauma\n\n          -  History of rheumatoid arthritis\n\n          -  History of malignancy\n\n          -  Pregnant\n\n          -  Patients requiring anti-platelet medication for the treatment of heart attack,\n             stroke, or other medical condition.\n\n          -  Previous surgery for lateral epicondylitis.\n\n          -  Previous local injections, including steroids within the past 6 months.\n\n          -  Signs of other causes for lateral elbow pain (posterior interosseous nerve\n             entrapment, osteochondral lesion)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01789632", 
            "org_study_id": "HUM00067750"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group A  Platelet Rich Plasma Injection (PRP)", 
                "description": "Local anesthetic (lidocaine)will be infiltrated into the subcutaneous tissue of the lateral elbow, after which a needle will then be placed into the tendon followed by 10-12 gentle strokes of dry needling in which the needle pierces the tendon at multiple sites. Whole blood will be drawn from the patient's unaffected arm using a butterfly needle. The blood will be centrifuged and then a dose of the platelet rich plasma will be placed into the common extensor tendon, and the remaining platelet rich plasma will be sent for analysis of platelet, white blood and red blood count concentrations.", 
                "intervention_name": "Group A Platelet Rich Plasma Injection (PRP)", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Group B Whole Blood Injection", 
                "description": "Local anesthetic (lidocaine)will be infiltrated into the subcutaneous tissue of the lateral elbow, after which a needle will then be placed into the tendon followed by 10-12 gentle strokes of dry needling in which the needle pierces the tendon at multiple sites. Autologous whole blood will be drawn from the patient's unaffected arm using a butterfly needle and a portion of this blood  will be placed into the common extensor tendon, and the remaining platelet rich plasma will be sent for analysis of platelet, white blood and red blood count concentrations.", 
                "intervention_name": "Group B  Whole Blood Injection", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Group C Dry needle tendon fenestration", 
                "description": "Local anesthetic (lidocaine)will be infiltrated into the subcutaneous tissue of the lateral elbow.  Autologous whole blood will be drawn from the patient's unaffected arm, using a butterfly needle and discarded.  The superficial subcutaneous soft tissue will be re-entered however, the tendon itself will not be entered and nothing will be injected.", 
                "intervention_name": "Group C Dry Needle tendon fenestration", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Group D  No injection", 
                "description": "Local anesthetic (lidocaine)will be infiltrated into the subcutaneous tissue of the lateral elbow.  Autologous whole blood will be drawn from the patient's unaffected arm using a butterfly needle.  The superficial subcutaneous soft tissues will be re-entered however, the tendon itself will not be entered and nothing will be injected.", 
                "intervention_name": "Group D  No injection", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 4, 2014", 
        "location": {
            "contact": {
                "email": "jjacobsn@umich.edu", 
                "last_name": "Jon Jacobson, MD", 
                "phone": "734-936-4365"
            }, 
            "contact_backup": {
                "email": "jemhill@umich.edu", 
                "last_name": "Jeanne Hill, LPN", 
                "phone": "734-647-9546"
            }, 
            "facility": {
                "address": {
                    "city": "Ann Arbor", 
                    "country": "United States", 
                    "state": "Michigan", 
                    "zip": "48109"
                }, 
                "name": "University of Michigan Hospital"
            }, 
            "investigator": {
                "last_name": "jon Jacobson, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Impact of Platelet Rich Plasma Over Alternative Therapies With LateralEpicondylitis (IMPROVE): A Multicenter, Randomized Trial Comparing Autologous Whole Blood Versus Dry Needle Tendon Fenestration of Pain and Quality of Life in Patients With Lateral Epicondylitis.", 
        "other_outcome": {
            "description": "Evaluation of psychological impairment as it has been shown to be increased in patients with lateral epicondylitis and has its own socioeconomic burden and symptoms related to anxiety and depression (such as decreased concentration, lack of motivation, chronic fatigue, poor sleep)will also likely influence the response to treatment.", 
            "measure": "Functional Disability", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "overall_contact": {
            "email": "jjacobsn@umich.edu", 
            "last_name": "Jon Jacobson, MD", 
            "phone": "734-936-4365"
        }, 
        "overall_contact_backup": {
            "email": "jemhill@umich.edu", 
            "last_name": "Jeanne Hill, LPN", 
            "phone": "734-647-9546"
        }, 
        "overall_official": {
            "affiliation": "University of Michigan Hospital", 
            "last_name": "Jon Jacobson, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Data and Safety Monitoring Board", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To demonstrate the feasibility of recruitment and adherence to the protocol over a 6 month recruitment period and 1 year follow-up period, which will include the following: 1) number of patients recruited during the 6 month period, 2) proportion of included patients followed at 1 year, 3) proportion of data forms completed at 1 year, 4) number of errors in randomization, 5) number of crossovers, 6)proportion of sites adhering to expertise-based randomization", 
            "measure": "Feasibility of recruitment and adherence to protocol", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01789632"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Michigan", 
            "investigator_full_name": "Jon Jacobson", 
            "investigator_title": "Primary Investigator", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "Assessment of reduction in pain", 
            "measure": "Assessment of pain", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "University of Michigan", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Jon Jacobson", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}